Plureon has entered into an agreement with BD (Becton, Dickinson & Company) in the field of diabetes research and development using Plureons platform stem cell technology. BD will sponsor Plureon's research efforts for up to three years and will be responsible for further development of the tech...

Plureons platform technology is a pluripotent stem cell which can be isolated harmlessly at birth from placental tissue which is otherwise usually discarded as medical waste. These stem cells, referred to as AFS cells in the scientific literature, have been differentiated into cells of all three ger...

Plureon Corporation (336) 612-3606 Home :: Technology :: News :: About Us :: Contact Us Plureon Corporation ...

Plureon is a privately owned biotechnology company located in Winston-Salem, North Carolina. Plureon was founded in early 2002 in order to develop technologies originating at the Laboratory for Cell Therapy and Tissue Engineering of Childrens Hospital Boston, a teaching affiliate of Harvard Medical ...

Click on a headline to show the full text of the story; click again to hide it. Use the "Contract All" or "Expand All" buttons to show or hide all news stories at once. Contract All | Expand All JDRF Partners With Plureon to Explore Generating Insulin-Producing Cells from Human Adult Stem Cells 2/4/...